Skip to main content
TipRanks
Go Ultimate75% OFF

Gland Pharma Ltd. (GLAND) Ratios

1 Followers

Gland Pharma Ltd. Ratios

IN:GLAND's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:GLAND's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio4.684.334.049.4610.05
Quick Ratio3.603.262.846.757.94
Cash Ratio2.091.630.262.620.54
Solvency Ratio0.670.510.571.131.96
Operating Cash Flow Ratio0.770.580.710.501.36
Short-Term Operating Cash Flow Coverage7.104.784.67649.947060.44
Net Current Asset Value₹ 53.74B₹ 47.09B₹ 37.08B₹ 60.82B₹ 51.76B
Leverage Ratios
Debt-to-Assets Ratio0.020.030.030.000.00
Debt-to-Equity Ratio0.030.030.040.000.00
Debt-to-Capital Ratio0.030.030.040.000.00
Long-Term Debt-to-Capital Ratio0.010.010.010.000.00
Financial Leverage Ratio1.211.231.221.101.09
Debt Service Coverage Ratio7.184.023.9194.60206.06
Interest Coverage Ratio36.2472.4569.56155.35302.17
Debt to Market Cap0.010.010.010.000.00
Interest Debt Per Share19.2320.5024.180.720.61
Net Debt to EBITDA-1.60-1.820.01-1.85-0.21
Profitability Margins
Gross Profit Margin30.05%56.16%54.92%48.70%48.89%
EBIT Margin23.29%15.53%17.15%24.40%31.81%
EBITDA Margin29.88%21.92%22.89%28.44%34.32%
Operating Profit Margin18.75%30.94%32.17%31.92%35.99%
Pretax Profit Margin22.77%18.92%19.99%29.10%36.78%
Net Profit Margin15.98%12.44%13.64%21.55%27.53%
Continuous Operations Profit Margin15.98%12.44%13.64%21.55%27.53%
Net Income Per EBT70.14%65.73%68.21%74.06%74.86%
EBT Per EBIT121.45%61.15%62.14%91.16%102.18%
Return on Assets (ROA)8.21%6.22%7.25%8.90%15.47%
Return on Equity (ROE)9.92%7.63%8.85%9.81%16.93%
Return on Capital Employed (ROCE)11.06%17.99%19.68%14.37%21.84%
Return on Invested Capital (ROIC)7.63%11.58%13.09%10.64%16.35%
Return on Tangible Assets8.48%6.43%7.49%8.91%15.49%
Earnings Yield3.68%2.73%2.59%3.74%2.25%
Efficiency Ratios
Receivables Turnover3.403.703.443.503.40
Payables Turnover5.393.002.963.174.86
Inventory Turnover2.581.461.520.941.83
Fixed Asset Turnover1.451.421.462.092.55
Asset Turnover0.510.500.530.410.56
Working Capital Turnover Ratio1.151.191.090.630.89
Cash Conversion Cycle181.19226.76222.48377.34231.57
Days of Sales Outstanding107.3598.55106.20104.32107.22
Days of Inventory Outstanding141.50249.83239.58388.30199.45
Days of Payables Outstanding67.66121.62123.29115.2975.10
Operating Cycle248.86348.38345.78492.63306.68
Cash Flow Ratios
Operating Cash Flow Per Share74.7355.5260.5122.1048.06
Free Cash Flow Per Share44.9432.1836.848.5516.33
Dividend Paid and CapEx Coverage Ratio1.561.282.561.631.51
Capital Expenditure Coverage Ratio2.512.382.561.631.51
Operating Cash Flow Coverage Ratio4.342.922.6881.74166.72
Operating Cash Flow to Sales Ratio0.190.160.180.100.18
Free Cash Flow Yield2.65%2.07%2.03%0.67%0.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio27.2036.6438.6826.7444.44
Price-to-Sales (P/S) Ratio4.354.565.275.7612.24
Price-to-Book (P/B) Ratio2.702.803.432.627.52
Price-to-Free Cash Flow (P/FCF) Ratio37.7448.2749.24148.28200.44
Price-to-Operating Cash Flow Ratio22.7027.9829.9857.3868.10
Price-to-Earnings Growth (PEG) Ratio0.58-3.83-33.98-0.752.61
Enterprise Value Multiple12.9418.9623.0518.4135.45
Enterprise Value248.70B233.52B298.95B189.80B535.37B
EV to EBITDA12.9418.9623.0518.4135.45
EV to Sales3.874.165.285.2412.17
EV to Free Cash Flow33.5844.0449.26134.76199.28
EV to Operating Cash Flow20.2025.5329.9952.1567.70
Tangible Book Value Per Share604.22533.96508.04482.60434.25
Shareholders’ Equity Per Share628.65555.45529.56483.30435.01
Tax and Other Ratios
Effective Tax Rate0.300.340.320.260.25
Revenue Per Share390.29340.92343.86220.11267.46
Net Income Per Share62.3542.4046.8947.4373.64
Tax Burden0.700.660.680.740.75
Interest Burden0.981.221.171.191.16
Research & Development to Revenue0.030.000.000.060.05
SG&A to Revenue0.080.250.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality1.201.311.290.350.49

Currency in INR